| 1 |
34582425 | Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock. | 2022 Apr 1 |
3 |
| 2 |
35156051 | Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study. | 2022 Feb |
2 |
| 3 |
35426141 | Machine learning to predict vasopressin responsiveness in patients with septic shock. | 2022 Jun |
2 |
| 4 |
34017842 | Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series. | 2021 |
1 |
| 5 |
31970567 | Vasopressin and its analogues in shock states: a review. | 2020 Jan 22 |
1 |
| 6 |
32488425 | Vasopressin in Patients with Septic Shock and Dynamic Left Ventricular Outflow Tract Obstruction. | 2020 Oct |
2 |
| 7 |
32616947 | Vasopressin for Septic Shock in a Medical-Surgical Intensive Care Unit. | 2020 May-Jun |
1 |
| 8 |
33196051 | Vasopressin in Conjunction With Norepinephrine in Septic Shock: A Retrospective Cohort Study From a Low Middle-Income Country. | 2020 Nov |
1 |
| 9 |
33282362 | Copeptin concentration following cardiac surgery as a prognostic marker of postoperative acute kidney injury: a prospective cohort study. | 2020 Nov |
1 |
| 10 |
28618919 | Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. | 2019 Oct |
2 |
| 11 |
28750598 | Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock. | 2019 Sep |
1 |
| 12 |
28820036 | Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock. | 2019 Nov-Dec |
4 |
| 13 |
31109431 | [Clinical progress of vasopressin in the treatment of septic shock]. | 2019 Apr |
2 |
| 14 |
31126701 | Effects of the discontinuation sequence of norepinephrine and vasopressin on hypotension incidence in patients with septic shock: A meta-analysis. | 2019 Nov - Dec |
1 |
| 15 |
31646370 | Vasopressor therapy in critically ill patients with shock. | 2019 Nov |
1 |
| 16 |
29336676 | Vasopressors in Sepsis. | 2018 Feb/Mar |
1 |
| 17 |
29600824 | Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock. | 2018 May |
4 |
| 18 |
29868972 | A global perspective on vasoactive agents in shock. | 2018 Jun |
1 |
| 19 |
30570030 | Use of vasopressin in the treatment of refractory septic shock. | 2018 Oct-Dec |
3 |
| 20 |
27630192 | Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock. | 2017 Jan |
1 |
| 21 |
28509668 | Norepinephrine in septic shock: when and how much? | 2017 Aug |
2 |
| 22 |
29319721 | Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline. | 2017 Dec |
5 |
| 23 |
27340145 | Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock. | 2016 Oct |
1 |
| 24 |
25655726 | Controversies regarding choice of vasopressor therapy for management of septic shock in animals. | 2015 Jan-Feb |
1 |
| 25 |
26523008 | Vasopressors and development of pressure ulcers in adult critical care patients. | 2015 Nov |
1 |
| 26 |
26612352 | Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? | 2015 Nov 27 |
1 |
| 27 |
24838480 | [Role of vasopressin in septic shock : critical evaluation]. | 2014 Jun |
1 |
| 28 |
25286297 | Severe sepsis during pregnancy. | 2014 Dec |
1 |
| 29 |
24099434 | On sepsis, troponin and vasopressin: the bitter truth. | 2013 Oct 8 |
1 |
| 30 |
21932058 | Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock. | 2012 Jun |
1 |
| 31 |
22127480 | Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. | 2012 Jan |
2 |
| 32 |
22518026 | The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock. | 2012 Sep |
1 |
| 33 |
22889256 | Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. | 2012 Aug 14 |
1 |
| 34 |
21519229 | Moderate-dose vasopressin therapy may impair gastric mucosal perfusion in severe sepsis: a pilot study. | 2011 Jun |
1 |
| 35 |
21892977 | Bench-to-bedside review: Vasopressin in the management of septic shock. | 2011 Aug 11 |
5 |
| 36 |
22234076 | Terlipressin facilitates gastric and autonomic system dysfunctions in liver cirrhosis. | 2011 Nov-Dec |
1 |
| 37 |
20606409 | Vasopressin and its immune effects in septic shock. | 2010 |
2 |
| 38 |
20874043 | Arginine vasopressin for the treatment of septic shock in adults. | 2010 Oct |
2 |
| 39 |
19237882 | Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. | 2009 Mar |
2 |
| 40 |
19239407 | Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. | 2009 May |
1 |
| 41 |
19664253 | Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. | 2009 |
1 |
| 42 |
19691565 | The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest. | 2009 Apr |
1 |
| 43 |
18687199 | Current place of vasopressin analogues in the treatment of septic shock. | 2008 Sep |
1 |
| 44 |
17379416 | Vasopressin for the septic burn patient. | 2007 Jun |
1 |
| 45 |
17599007 | Vasopressin in vasodilatory and septic shock. | 2007 Aug |
2 |
| 46 |
18265860 | Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. | 2007 |
1 |
| 47 |
16484914 | Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. | 2006 Apr |
2 |
| 48 |
16489848 | Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature. | 2006 |
3 |
| 49 |
16503921 | Site of ATP and phenylephrine synergistic stimulation of vasopressin release from the hypothalamo-neurohypophyseal system. | 2006 Apr |
1 |
| 50 |
16570552 | Septic shock in the postoperative patient: three important management decisions. | 2006 Mar |
1 |